Daniel Bruetman,MD, MMM

MD, MMM

Medical Oncologist

Bruetman-Daniel-CHI
quotation

It’s important to me that I not only provide the best medical care for my patients, but that they know they can trust me as a partner through every step of their cancer journey.

Location
City of Hope Downtown Chicago
160 Upper E. Illinois St.
Chicago, IL 60611
Specialties
Medical Oncology
Education
Medical school:

University of Buenos Aires School of Medicine, Buenos Aires, Argentina

Residency:

Internal Medicine - Advocate Christ Medical Center, Oak Lawn, IL

Fellowship:

Medical Oncology - Rush University Medical Center, Chicago, IL

Certifications

Board Certified in Internal Medicine - American Board of Internal Medicine

Board Certified in Medical Oncology - American Board of Internal Medicine

About Me

Daniel Bruetman, MD, MMM, joined City of Hope in February 2023 at the City of Hope Outpatient Care Center (OCC) in downtown Chicago, Illinois. As a Medical Oncologist, Dr. Bruetman evaluates and treats patients with a variety of types and stages of cancer, with a special focus on breast cancer.

Dr. Bruetman returned to City of Hope after serving for 19 years as Director of Medical Oncology at the Goshen Center for Cancer Care in Goshen, Indiana, and the values that inform the Mother Standard® of care—how City of Hope treats all patients the way we’d want our own family to be treated—have resonated with him ever since.

“After my wife and I moved back to Chicago, I was thrilled to learn of an opening for a Medical Oncologist at the City of Hope Downtown Chicago location,” he said. “I feel strongly that providing the best possible cancer care requires an integrative, personalized approach, and I know firsthand that City of Hope is driven by these same ideals.”

Dr. Bruetman also completed a master’s degree in the medical management program at Carnegie Mellon University. He now brings over 30 years of oncology experience to the Outpatient Care Center, as well as leadership expertise after overseeing the development of integrative cancer treatment programs. He also has conducted extensive research on leading-edge innovations in cancer care and worked as a clinical instructor in internal medicine at local hospitals.

A career in oncology made sense to Dr. Bruetman because he was interested in treating the whole person, rather than focusing on any single part of the body. As a bilingual (English/Spanish) oncologist, Dr. Bruetman enjoys making long-term connections with his patients to better support them on a personal level. “Patients don't care how much you know until they know how much you care,” he says.

Dr. Bruetman earned his medical degree from the University of Buenos Aires School of Medicine in Buenos Aires, Argentina, then completed an internal medicine residency at Advocate Medical Center in Oak Lawn, Illinois and a medical oncology fellowship at Rush University Medical Center in Chicago, Illinois. Board-certified in internal medicine and medical oncology, he received his Master of Medical Management from Carnegie Mellon University in Pittsburgh, Pennsylvania.

Outside of City of Hope, Dr. Bruetman lives with his wife in Downtown Chicago and enjoys regular visits with his son and daughter, both of whom also live in Chicago. He and his wife are avid concert-goers, frequenting local jazz clubs and performances by the Chicago Symphony Orchestra. A passionate wine collector who loves visiting wine regions throughout the world with his wife, Dr. Bruetman also enjoys getting his exercise from yoga, Pilates and long walks.

Patient ratings
Star ratings and comments are only available for medical, radiation and gynecologic oncologists. Gynecologic surgical offerings are not included at this time due to a different survey tool required to evaluate these services. CTCA uses a validated Press Ganey® survey, which captures patient experience feedback for the primary oncology services of chemotherapy and radiation therapy at our comprehensive care and research centers. Following industry best practice, star ratings and comments are only published for physicians with a minimum of 30 completed patient surveys.